Back to the Top
Hello,
I am a first year pharm. D student who is researching a project
comparing 81 mg aspirin doses brand name vs. generic brands (enteric
coated). I have heard that there might be some biavailability problems
with the generic enteric coated aspirin products, but I haven't been able
to find any real data on this. Does anyone have any suggestions?
Thanks ahead of time,
Brad Hein, RPh
Back to the Top
Dear Bradley,
you might try to search the issue of aspirin kinetics under the name of
Gerhard Levy, PharmD, He "wrote the book" on the issue of aspirin
kinetics, dosage form effects, absorption, etc.
Best Regards
Jim Axelson
Back to the Top
You may have already thought of this, but have you referred to the
OTC handbook (by APhA)? Since this is a referenced text, it may
contain the citation for your question. Good luck.
Arasb Ateshkadi, Pharm.D.
Assistant Professor
Department of Pharmacy Practice
College of Pharmacy
University of Utah
258 Skaggs Hall
Salt Lake City, UT 84112
TEL: (801) 581-6159
FAX: (801) 585-6160
e-mail: arasb.aaa.deans.pharm.utah.edu
Back to the Top
It's my impression that companies making generics must file data with the
FDA to prove bioequivalence. You might consider calling the companies and
having them send you a copy of the report they filed with FDA.
Steven C. Ebert, Pharm.D., FCCP
Clinical Specialist, Infectious Diseases
Clinical Associate Professor of Pharmacy
Department of Pharmacy, Meriter Hospital
202 S. Park Street
Madison, WI 53715
Ph: (608)-267-6035
Fx: (608)-267-6022
Want to post a follow-up message on this topic?
If this link does not work with your browser send a follow-up message to PharmPK@lists.ucdenver.edu with "Aspirin bioavailability" as the subject | Support PharmPK by considering my eBooks |
Copyright 1995-2014 David W. A. Bourne (david@boomer.org)